Daewon Pharmaceutical (003220) has 5 disclosed insider purchases and 1 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩149M ($103K) in reported transaction value. The earliest filing StockDrifts holds for Daewon Pharmaceutical is dated 2024-01-01; the most recent is 2026-06-08. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -5.07%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-06-08 | SELL | 증여 | 임한일 Lim Han-il | vice president | -15.0K | ₩12,400 | +23.9% | ₩186M ($129K) |
| 2026-03-12 | BUY | Market Buy | 임한일 Lim Han-il | vice president | 1.1K | - | - | - |
| 2026-03-11 | BUY | Market Buy | 임한일 Lim Han-il | vice president | 1.9K | - | - | - |
| 2025-02-18 | BUY | Market Buy | 임한일 Lim Han-il | vice president | 2.0K | ₩14,510 | -17.7% | ₩29M ($20K) |
| 2025-02-17 | BUY | Market Buy | 임한일 Lim Han-il | vice president | 1.0K | ₩14,460 | -17.4% | ₩14M ($10K) |
| 2025-01-01 | BUY | 신규선임 | 강종환 Jong-hwan Kang | moving | 708 | ₩14,400 | -17.1% | ₩10M ($7K) |
| 2024-09-05 | BUY | Market Buy | 임한일 Lim Han-il | vice president | 3.2K | ₩14,200 | -15.9% | ₩46M ($32K) |
| 2024-07-18 | SELL | Market Sell | 강주인 Kang Joo-in | moving | -3.4K | ₩17,250 | +30.8% | ₩59M ($41K) |
| 2024-01-01 | BUY | 신규선임 | 오준일 Oh Jun-il | moving | 1.1K | ₩15,880 | -24.8% | ₩17M ($12K) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Daewon Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.